XML 26 R17.htm IDEA: XBRL DOCUMENT v3.22.1
Debt
 3 Months Ended
Apr. 02, 2022
Debt Disclosure [Abstract]  
Debt Debt
Debt consists of the following (in thousands):
April 2, 2022January 1, 2022
Amended Credit Agreement:  
Revolving Credit Facility ($8.0 million denominated in C$ at April 2, 2022)
$396,007 $160,000 
Term Loan B
200,000 200,000 
Less unamortized deferred loan costs(1,774)(1,928)
Carrying value Term Loan B198,226 198,072 
5.25% Senior Notes due 2027 with effective interest of 5.47%
500,000 500,000 
Less unamortized deferred loan costs(4,753)(4,959)
Carrying value 5.25% Senior Notes due 2027
495,247 495,041 
3.625% Senior Notes due 2026 - Denominated in euro with effective interest of 3.83%
568,972 582,980 
Less unamortized deferred loan costs - Denominated in euro(4,647)(5,031)
Carrying value 3.625% Senior Notes due 2026
564,325 577,949 
Other Notes and Obligations59,457 32,319 
1,713,262 1,463,381 
Less Current Maturities35,337 24,407 
$1,677,925 $1,438,974 

As of April 2, 2022, the Company had outstanding debt under the Company's 3.625% Senior Notes due 2026 denominated in euros of €515.0 million. In addition, at April 2, 2022, the Company had finance lease obligations denominated in euros of approximately €4.3 million.

As of April 2, 2022, the Company had outstanding borrowings under the Company's amended credit agreement denominated in Canadian dollars of C$10.0 million.
As of April 2, 2022, the Company had other notes and obligations of $59.5 million that consist of various overdraft facilities of approximately $9.9 million, a China working capital line of credit of approximately $20.5 million and other debt of approximately $29.1 million.

On January 6, 2014, Darling, Darling International Canada Inc. (“Darling Canada”) and Darling International NL Holdings B.V. (“Darling NL”) entered into a Second Amended and Restated Credit Agreement (as subsequently amended, the “Amended Credit Agreement”), restating its then existing Amended and Restated Credit Agreement dated September 27, 2013, with the lenders from time to time party thereto, JPMorgan Chase Bank, N.A., as Administrative Agent, and the other agents from time to time party thereto. Effective March 2, 2022, the Company, and certain of its subsidiaries entered into an amendment (the "Eighth Amendment") with its lenders to the Amended Credit Agreement. Among other things, the Eighth Amendment (a) added a new delayed draw incremental term facility (the “term A-2 facility”) and new incremental Term Loans pursuant thereto, in an aggregate principal amount of up to $500.0 million, which is available to the Company for general corporate purposes, including acquisitions and capital expenditures, and will mature on December 9, 2026 and (b) updated and modified certain other terms and provisions of the Amended Credit Agreement to reflect the addition of the term A-2 facility to the Amended Credit Agreement.

The interest rate applicable to any borrowings under the revolving loan facility will equal the adjusted term secured overnight financing rate (SOFR) for U.S. dollar borrowings or the adjusted euro interbank rate (EURIBOR) for euro borrowings or the adjusted daily simple Sterling overnight index average (SONIA) for British pound borrowings or CDOR for Canadian dollar borrowings plus 1.25% per annum or base rate or the adjusted term SOFR for U.S. dollar borrowings or Canadian prime rate for Canadian dollar borrowings or the adjusted daily simple European short term rate (ESTR) for euro borrowings or the adjusted daily SONIA rate for British pound borrowings plus 0.25% per annum subject to certain step-ups or step-downs based on the Company's total leverage ratio. The interest rate applicable to any borrowing under the delayed draw term A-1 facility will equal the adjusted term SOFR plus a minimum of 1.50% per annum subject to certain step-ups based on the Company's total leverage ratio. The interest rate applicable to any borrowing under the delayed draw term A-2 facility will equal the adjusted term SOFR plus a minimum of 1.00% per annum subject to certain step-ups based on the Company's total leverage ratio. The interest rate applicable to any borrowings under the term loan B facility will equal the base rate plus 1.00% or LIBOR plus 2.00%.

As of April 2, 2022, the Company had $70.0 million outstanding under the revolver at base rate plus a margin of 0.25% per annum for a total of 3.75% per annum and $318.0 million outstanding under the revolver as SOFR plus a margin of 1.25% per annum for a total of 1.625%. The Company had $200.0 million outstanding under the term loan B facility at LIBOR plus a margin of 2.00% per annum for a total of 2.25% per annum. The Company had C$10.0 million outstanding under the revolver at CDOR plus a margin of 1.25% per annum for a total of 2.12%. As of April 2, 2022, the Company had revolving loan facility availability of $1,049.7 million, availability on a delayed draw term A-1 facility of $400.0 million and availability on a delayed draw term A-2 facility of $500.0 million under the Amended Credit Agreement taking into account amounts borrowed, ancillary facilities of $50.4 million and letters of credit issued of $3.8 million. The Company also has foreign bank guarantees that are not part of the Company's Amended Credit Agreement in the amount of approximately $11.8 million at April 2, 2022. The Company capitalized approximately $1.3 million of deferred loan costs as of April 2, 2022 in connection with the Eighth Amendment.

As of April 2, 2022, the Company believes it is in compliance with all of the financial covenants under the Amended Credit Agreement, as well as all of the other covenants contained in the Amended Credit Agreement, the 5.25% Senior Notes due 2027 and the 3.625% Senior Notes due 2026.